Combined Ratio (Annual)

Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned

ADMA Biologics Inc (ADMA) Combined Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$426.45M
Net Income	$197.67M
Cost of Goods Sold	$206.90M
Gross Profit	$219.55M
Operating Expenses	$287.47M
Operating Income	$138.98M
Non-Operating Income/Expense	$-13.27M
Pre-Tax Income	$125.71M
Normalized Pre-Tax Income	$125.71M
Income after Taxes	$197.67M
Income from Continuous Operations	$197.67M
Consolidated Net Income/Loss	$197.67M
Normalized Income after Taxes	$197.67M
EBIT	$138.98M
EBITDA	$147.84M
Weighted-Average Shares Outstanding (Basic)	233.08M
Weighted-Average Shares Outstanding (Diluted)	243.34M
Earnings per Share (EPS) (Basic)	$0.85
Earnings per Share (EPS) (Diluted)	$0.81
Balance Sheet Financials
Current Assets	$331.41M
Property, Plant, and Equipment	$54.71M
Long-Term Assets	$157.27M
Total Assets	$488.68M
Current Liabilities	$55.54M
Long-Term Debt	$80.90M
Long-Term Liabilities	$84.12M
Total Liabilities	$139.66M
Common Equity	$349.02M
Tangible Shareholders Equity	$345.03M
Shareholders Equity	$349.02M
Common Shares Outstanding	236.62M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$118.67M
Cash Flow from Investing Activities	$-8.57M
Cash Flow from Financial Activities	$-58.30M
Beginning Cash	$51.35M
End Cash	$103.15M
Increase/Decrease in Cash	$51.80M
Stock-Based Compensation	$13.62M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.97
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.19
Debt to Equity Ratio	0.24
Gross Margin	51.48%
Operating Margin	32.59%
EBIT Margin	32.59%
EBITDA Margin	34.67%
Pre-Tax Profit Margin	29.48%
Profit Margin	46.35%
Free Cash Flow	$110.45M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.87
Inventory Turnover	1.22
Receiveable Turnover	8.53
Days Sales in Receivables	42.79
Return on Equity	56.64%
Return on Tangible Equity	57.29%
Return on Assets	40.45%
Return on Investments	45.98%
Book Value Per Share	$1.48
Free Cash Flow per Share	$0.45
Operating Cash Flow per Share	$0.49

Data from Zacks Investment Research, Inc.